Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,046,596
-$6,620,230 QoQ
Shares Held
67,742
-37.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#683
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRED ALGER MANAGEMENT, LLC holds $736,177,545 across 12 Drug Manufacturers - General names. ABBV ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
4,907,570 | $235,268,905 | |
| 2 | BIIB |
Biogen Inc.
|
788,307 | $170,321,610 | |
| 3 | JNJ |
Johnson & Johnson
|
444,151 | $112,801,029 | |
| 4 | LLY |
ELI LILLY & Co
|
75,669 | $90,759,676 | |
| 5 | MRK |
Merck & Co., Inc.
|
487,735 | $62,673,947 | |
| 6 | AZN |
Astrazeneca PLC
|
138,797 | $26,318,686 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
67,742 | $17,046,596 | |
| 8 | AMGN |
Amgen Inc
|
14,074 | $5,096,476 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,046,596 | 67,742 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $23,666,826 | 108,818 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,008,102 | 113,826 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,599,293 | 110,561 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,436,670 | 56,226 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $88,740,100 | 423,540 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $15,219,471 | 85,647 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,294,032 | 102,765 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,996,508 | 87,433 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $20,958,799 | 115,095 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,869,729 | 63,688 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,687,328 | 98,533 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $24,652,356 | 182,976 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $151,156,070 | 948,460 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $270,771,575 | 1,675,463 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $202,653,610 | 1,509,974 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $196,052,304 | 1,280,049 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $252,411,916 | 1,557,041 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $243,395,717 | 1,797,605 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,334,477 | 30,912 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $13,525,698 | 120,079 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $31,547,320 | 291,511 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $80,587,515 | 752,100 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,227,576 | 82,516 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $16,663,895 | 169,728 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $39,373,772 | 516,784 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||